Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Group A â?? 20 patients will be administered Virechana Karma within
duration of 15 days as per following plan followed by Vidangadi Churna
3gm twice a day for 30 days. ch.su.23/ 8
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: corticosteroids,antidepressants,anticholinergics, immunosuppressant, oestrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study. c)Symptomatic patient with clinical evidence of Heart failure. d)Patients with poorly controlled hypertension (systolic >180 and diastolic >100 mm ofHg) e)Patients with evidence of malignancy. f)Patients on oral contraceptives. g)Alchohol and /or drug abusers. h)Hyper
Exclusion criteria
Exclusion criteria: a)Unstable angina: Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or severe Arrhythmia in the last six months. b)Patients on prolonged ( >6weeks) medication with corticosteroids,antidepressants,anticholinergics, immunosuppressant, oestrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study. c)Symptomatic patient with clinical evidence of Heart failure. d)Patients with poorly controlled hypertension (systolic >180 and diastolic >100 mm ofHg) e)Patients with evidence of malignancy. f)Patients on oral contraceptives. g)Alchohol and /or drug abusers. h)Hypersensitivity to any of the trial drugs or their ingredients. i)Patients who have completed participation in any other clinical trial drugs or theiringredients in one month period. j)Patients who have received any cholesterol lowering medication (Modern Drug) within last two weeks. k)Associated with any rectal pathology like haemorrhoids, fissure not fit for Virechanaand Basti Karma etc. l)Pregnancy, Lactation and patients having Dyslipidaemia due to drugs e.g.Glucocorticoids, Diuretics etc. m)Patients having Lipid Profile-Serum Cholesterol >400mg dl, Serum Triglycerides > 400mg/dl, LDL Cholesterol > 250 mg/dl,HDL Cholesterol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in lipid profile Change in BMI and BMI Prime. Change in anthropometric parameters Timepoint: Changes in lipid profile - 45 days Change in BMI and BMI Prime. -45 days Change in anthropometric parameters -45 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in Cardiac risk will be assessed by Framinghms 10 years cardiac risk scoreTimepoint: After completion of trial 45 days | — |
Countries
India
Contacts
Public ContactDr Santvana Sharma
National Institute of Ayurveda Jaipur302002
Outcome results
None listed